Home › Maxim Group Cuts Cytori Therapeutics Price Target to $5.00
 

Keywords :   


Maxim Group Cuts Cytori Therapeutics Price Target to $5.00

2015-08-09 03:47:14| Biotech - Topix.net

Separately, Roth Capital restated a "buy" rating and issued a $6.00 target price on shares of Cytori Therapeutics in a research note on Tuesday, June 16th. Shares of Cytori Therapeutics traded up 2.5122% during midday trading on Friday, reaching $0.4203.

Tags: price group target cuts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Tropical Storm Joyce Wind Speed Probabilities Number 7
29.09Tropical Storm Joyce Forecast Discussion Number 7
More »